Physician profile
Raj Singh
NPI 1255836953
$2,316.93
in general payments reported to CMS, 2019-2025
11 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $164 · 2022: $480 · 2023: $254 · 2024: $891 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $816 · Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $815.59 |
| Food and Beverage | $736.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $890.69 | 2024 | Icotec Blackarmor Spine System |
| Boston Scientific Corporation | $331.95 | 2022 | |
| Gt Medical Technologies, INC | $297.01 | 2025 | Gammatile |
| Novocure INC. | $169.09 | 2023 | Optune |
| Cvrx, INC. | $164.05 | 2021 | |
| Roche Diagnostics Corporation | $120.16 | 2022 | |
| Galderma Laboratories, L.P. | $110.23 | 2025 | Nemluvio |
| Astrazeneca Pharmaceuticals LP | $103.18 | 2019 | |
| Siemens Medical Solutions USA, INC. | $85.15 | 2023 | Varian Identify, Edge |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.95 | 2022 | |
| Lundbeck LLC | $17.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.